← Research LibraryThe BriefFY2025 10-K · headline figures audited against SEC data
Connect Biopharma Holdings Ltd: Revenue declined 99.8% to $64K from $26.03M. Net loss widened to $55.48M from $15.63M. Free cash flow outflow widened to $51.64M from $24.36M. Operating margin contracted 9065439 bps to -90740.63%. Connect Biopharma Holdings Ltd's annual comparison also shows the manipulation screen is flagged and should be investigated as a warning rather than treated as proof; the balance-sheet screen falls in the distress range and requires business-model context; the earnings-quality screen is distress.
The read at a glance✓ Audited against SEC data
- Growth — Revenue declined 99.8% to $64K from $26.03MWatch
- Profitability — Net loss widened to $55.48M from $15.63MWatch
- Cash flow — Free cash flow outflow widened to $51.64M from $24.36MWatch
- Margins — Operating margin contracted 9065439 bps to -90740.63%Watch
- Accounting — Flagged statistical warning; not proofWatch
- Insiders — 1 purchase and 0 salesOK
Business
Significant Unmet Need and Market Opportunity in Asthma Asthma is a chronic inflammatory disease that affects the airways in the lungs and makes it difficult to breathe.
Where the revenue comes from
Fiscal 2025, as Connect Biopharma Holdings Ltd reports it. History and quarterly detail are in the app.
- Clinical Trial Reports$100K
Leadership changes
From Connect Biopharma Holdings Ltd's own filings, the day they're filed.
- James A. Schoeneck · Chief Executive Officer · appointment
Latest filings
- 8-K · Company announcement2026-08-12
- 10-Q · Quarterly report2026-08-12
- 8-K · Company announcement2026-05-12
- 10-Q · Quarterly report2026-05-12
- 8-K · Company announcement2026-04-23
In the full recordFree for 14 days
- What changed🔒
- Insider signal🔒
- Growth quality🔒
- Margins & accounting🔒
- Capital allocation🔒
- Real risks🔒
- The long arc🔒
- Company history🔒
- The filings, readable — with what changed vs the prior year highlighted🔒
- Full financial statements, industry-aware, sources cited throughout🔒
- Forensic score history & components — the trend, not one year🔒
- Ownership: insider buys/sells, clusters, activist stakes🔒
- Ana — ask about Connect Biopharma Holdings Ltd, every answer cited to the official filings🔒
Every figure comes from the company's filings, and analysis whose figures don't match SEC data is rejected before publication.
14-day free trial, no credit card. For research purposes only; not investment advice.